Brief: Sumitomo Pharma Co Ltd Orgovyx Is Expected To Be Available For Prescription In Canada In Q1 2024
23/10/2023 13:57
Oct 23 (Reuters) - Sumitomo Pharma Co Ltd 4506.T :
* SUMITOMO PHARMA CO LTD: ORGOVYX IS EXPECTED TO BE
AVAILABLE FOR
PRESCRIPTION IN CANADA IN Q1 2024
Source text for Eikon: ID:nCNWW3q1ja
Further company coverage: 4506.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sumitomo Pharma
See all newsSumitomo Pharma America Announces First Patient Receives Treatment In Phase 1/2A Study For Investigational Therapy Dsp-3077 For Retinitis Pigmentosa
Regarding A Report Concerning Sumitomo Pharma ( Company's Views On Gcr August 7 Report)
Brief: Sumitomo Pharma - Gotham City Research's August 3 Report Contains Numerous Statements That Are Clearly Inconsistent With Facts
Brief: Gotham City Research Holds Short Positions In Sumitomo Chemical And Sumitomo Pharmaceutical
Table: Sumitomo Pharma -Q1 group results (IFRS)